Muhammad Irshad1, Mohammad Khursheed Alam2, Sajid Ali3, Ahmad Alawneh4, Mohammed Alhadi5, Ahmed Alhadi6, Ahmed Ali Alfawzan7. 1. Department of Oral Pathology, Rehman College of Dentistry, Peshawar, Pakistan. 2. Department of Preventive Dentistry, College of Dentistry, Jouf University, Sakaka 72345, Saudi Arabia. 3. Department of Prosthodontics, Rehman College of Dentistry, Peshawar, Pakistan. 4. Jordanian Royal Medical Services, Dental Department, Jordan. 5. Aljouf Specialist Dental Center, MOH, Sakaka 72345, Saudi Arabia. 6. Ministry of Health in Saudi Arabia, Saudi Arabia. 7. Department of Preventive Dentistry, College of Dentistry in Ar Rass, Qassim University, Ar Rass, Saudi Arabia.
Abstract
OBJECTIVE: To investigate the role of implant surface debridement alone and in conjunction with systemic antibiotics on the clinical and microbiological variables of periimplantitis. MATERIALS AND METHODS: Data of forty-six patients with at least one dental implant having bleeding-on-probing (BoP), probing pocket depth (PPD) of more than 5 mm, and radiographic bone loss of more than 3 mm were retrieved from clinical records. Data was recorded for dental implant with the deepest PPD, BoP, and bone loss from each patient. "Group-A" received implant surface debridement alone, while "group-B" additionally received systemic antibiotics. Clinical and microbiological data of patients were compared before and after the treatment. RESULTS: At the implant level, a significant reduction of PPD, mucosal recession (MR), and BoP was achieved for all patients. Group B achieved significant improvement in MR and BoP compared to group A at implant level. PPD, MR, and plaque scores showed improvement at implant site level. At 3 months recall visit, 44% of group A and 52% of group B implants required surgical treatment. The presence and proportions of studied bacteria of both groups did not differ significantly at the recall visit when compared to the initial visit. However, P. intermedia and P. micros showed a significant reduction in group A at the recall visit. CONCLUSIONS: Implant surface debridement improved the clinical parameters of periimplantitis. In addition, adjunctive use of systemic antibiotics increased mucosal recession and improved bleeding on probing in periimplantitis.
OBJECTIVE: To investigate the role of implant surface debridement alone and in conjunction with systemic antibiotics on the clinical and microbiological variables of periimplantitis. MATERIALS AND METHODS: Data of forty-six patients with at least one dental implant having bleeding-on-probing (BoP), probing pocket depth (PPD) of more than 5 mm, and radiographic bone loss of more than 3 mm were retrieved from clinical records. Data was recorded for dental implant with the deepest PPD, BoP, and bone loss from each patient. "Group-A" received implant surface debridement alone, while "group-B" additionally received systemic antibiotics. Clinical and microbiological data of patients were compared before and after the treatment. RESULTS: At the implant level, a significant reduction of PPD, mucosal recession (MR), and BoP was achieved for all patients. Group B achieved significant improvement in MR and BoP compared to group A at implant level. PPD, MR, and plaque scores showed improvement at implant site level. At 3 months recall visit, 44% of group A and 52% of group B implants required surgical treatment. The presence and proportions of studied bacteria of both groups did not differ significantly at the recall visit when compared to the initial visit. However, P. intermedia and P. micros showed a significant reduction in group A at the recall visit. CONCLUSIONS: Implant surface debridement improved the clinical parameters of periimplantitis. In addition, adjunctive use of systemic antibiotics increased mucosal recession and improved bleeding on probing in periimplantitis.
Authors: Manuel Toledano-Osorio; Cristina Vallecillo; Raquel Toledano; Fátima S Aguilera; María T Osorio; Esther Muñoz-Soto; Franklin García-Godoy; Marta Vallecillo-Rivas Journal: Int J Environ Res Public Health Date: 2022-05-26 Impact factor: 4.614